- Title
- The Benefit of Targeted and Selective Inhibition of the Alternative Complement Pathway for Modulating Autoimmunity and Renal Disease in MRL/lpr Mice
- Creators
- Hideharu SEKINE - Medical University of South Carolina, Charleston, United StatesTING TING HSIEH TING TING HSIEH KINSER - Medical University of South Carolina, Charleston, United StatesFEI FEI QIAO - Medical University of South Carolina, Charleston, United StatesEfrain MARTINEZ - Medical University of South Carolina, Charleston, United StatesEmily PAULLING - Medical University of South Carolina, Charleston, United StatesPhillip RUIZ - University of Miami School of Medicine, Miami, Florida, United StatesGary S GILKESON - Medical University of South Carolina, Charleston, United StatesStephen TOMLINSON - Medical University of South Carolina, Charleston, United States
- Publication Details
- Arthritis and rheumatism, Vol.63(4), pp.1076-1085
- Publisher
- Wiley; Hoboken , NJ
- Academic Unit
- Miller School of Medicine; UMMG Department of Surgery; UMMG Dept of Surgery - Div of General Surgery
- Language
- English
- Resource Type
- Journal article
- PMID
- 21452327
- Record Identifier
- 991031577331702976
Journal article
The Benefit of Targeted and Selective Inhibition of the Alternative Complement Pathway for Modulating Autoimmunity and Renal Disease in MRL/lpr Mice
Arthritis and rheumatism, Vol.63(4), pp.1076-1085
2011
PMID: 21452327
Metrics
20 Record Views
InCites Highlights
These are selected metrics from InCites Benchmarking & Analytics tool, related to this output
- Collaboration types
- Domestic collaboration
- Citation topics
- 1 Clinical & Life Sciences
- 1.286 Immunology & Hematology
- 1.286.845 Complement
- Web Of Science research areas
- Rheumatology
- ESI research areas
- Clinical Medicine
UN Sustainable Development Goals (SDGs)
This output has contributed to the advancement of the following goals:
Source: InCites